THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE

Details for Australian Patent Application No. 2002359579 (hide)

Owner CURAGEN CORPORATION

Inventors ZHONG, Haihong; ZHONG, Mei; ALSOBROOK, John, P., II; ANDERSON, David, W.; BOLDOG, Ferenc, L.; BURGESS, Catherine, E.; CHILLAKURU, Rajeev, A.; EDINGER, Shlomit, R.; GERLACH, Valerie, L.; GORMAN, Linda; GOULD-ROTHBERG, Bonnie, E.; GUO, Xiaojia; JEFFERS, Michael, E.; JI, Weizhen; LI, Li; MALYANKAR, Uriel, M.; MILLER, Charles, E.; MURPHEY, Ryan; PATTURAJAN, Meera; PEYMAN, John, A.; RASTELLI, Luca; RIEGER, Daniel, K.; SHENOY, Suresh, G.; SMITHSON, Glennda; STARLING, Gary; TAUPIER, Raymond, J., Jr.; VOSS, Edward

Pub. Number AU-A-2002359579

PCT Number PCT/US02/38594

PCT Pub. Number WO2003/050245

Priority 60/336,600 05.12.01 US; 60/338,285 07.12.01 US; 60/341,346 12.12.01 US; 60/341,540 17.12.01 US; 60/341,477 17.12.01 US; 60/342,592 20.12.01 US; 60/344,297 27.12.01 US; 60/344,903 31.12.01 US; 60/373,288 17.04.02 US; 60/380,981 15.05.02 US; 60/381,495 17.05.02 US; 60/383,744 28.05.02 US; 60/383,534 28.05.02 US; 60/383,829 29.05.02 US; 60/384,024 29.05.02 US; 60/401,788 07.08.02 US; 60/406,353 26.08.02 US; Not Given 31.10.02 US; Not Given 02.12.02 US

Filing date 3 December 2002

Wipo publication date 23 June 2003

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/336,600 05.12.01 US; 60/338,285 07.12.01 US; 60/341,346 12.12.01 US; 60/341,540 17.12.01 US; 60/341,477 17.12.01 US; 60/342,592 20.12.01 US; 60/344,297 27.12.01 US; 60/344,903 31.12.01 US; 60/373,288 17.04.02 US; 60/380,981 15.05.02 US; 60/381,495 17.05.02 US; 60/383,744 28.05.02 US; 60/383,534 28.05.02 US; 60/383,829 29.05.02 US; 60/384,024 29.05.02 US; 60/401,788 07.08.02 US; 60/406,353 26.08.02 US; Not Given 31.10.02 US; Not Given 02.12.02 US

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002359579

20 July 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002359580-INSULIN-RESPONSIVE DNA BINDING PROTEIN-1 AND METHODS TO REGULATE INSULIN-RESPONSIVE GENES

2002359578-FED CATHODE STRUCTURE USING ELECTROPHORETIC DEPOSITION